Literature DB >> 19864428

Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation.

Tomoko Sunami1, Noel Byrne, Ronald E Diehl, Kaoru Funabashi, Dawn L Hall, Mari Ikuta, Sangita B Patel, Jennifer M Shipman, Robert F Smith, Ikuko Takahashi, Joan Zugay-Murphy, Yoshikazu Iwasawa, Kevin J Lumb, Sanjeev K Munshi, Sujata Sharma.   

Abstract

p70 ribosomal S6 kinase (p70S6K) is a downstream effector of the mTOR signaling pathway involved in cell proliferation, cell growth, cell-cycle progression, and glucose homeostasis. Multiple phosphorylation events within the catalytic, autoinhibitory, and hydrophobic motif domains contribute to the regulation of p70S6K. We report the crystal structures of the kinase domain of p70S6K1 bound to staurosporine in both the unphosphorylated state and in the 3'-phosphoinositide-dependent kinase-1-phosphorylated state in which Thr-252 of the activation loop is phosphorylated. Unphosphorylated p70S6K1 exists in two crystal forms, one in which the p70S6K1 kinase domain exists as a monomer and the other as a domain-swapped dimer. The crystal structure of the partially activated kinase domain that is phosphorylated within the activation loop reveals conformational ordering of the activation loop that is consistent with a role in activation. The structures offer insights into the structural basis of the 3'-phosphoinositide-dependent kinase-1-induced activation of p70S6K and provide a platform for the rational structure-guided design of specific p70S6K inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864428      PMCID: PMC2836063          DOI: 10.1074/jbc.M109.040667

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

Review 2.  Regulation of protein kinases; controlling activity through activation segment conformation.

Authors:  Brad Nolen; Susan Taylor; Gourisankar Ghosh
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

3.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

Review 4.  Structural insights into the conformational selectivity of STI-571 and related kinase inhibitors.

Authors:  Clifford D Mol; Doriano Fabbro; David J Hosfield
Journal:  Curr Opin Drug Discov Devel       Date:  2004-09

5.  Identification and characterization of a constitutively T-loop phosphorylated and active recombinant S6K1: expression, purification, and enzymatic studies in a high capacity non-radioactive TR-FRET Lance assay.

Authors:  Wei-Guo Zhang; Boris Shor; Ker Yu
Journal:  Protein Expr Purif       Date:  2005-09-19       Impact factor: 1.650

6.  Structure of S6 kinase 1 determines whether raptor-mTOR or rictor-mTOR phosphorylates its hydrophobic motif site.

Authors:  Siraj M Ali; David M Sabatini
Journal:  J Biol Chem       Date:  2005-04-04       Impact factor: 5.157

7.  Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.

Authors:  Christine B Breitenlechner; Walter-Gunar Friebe; Emmanuel Brunet; Guido Werner; Klaus Graul; Ulrike Thomas; Klaus-Peter Künkele; Wolfgang Schäfer; Michael Gassel; Dirk Bossemeyer; Robert Huber; Richard A Engh; Birgit Masjost
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

8.  Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis.

Authors:  Xiao-Feng Le; Walter N Hittelman; Jiaxin Liu; Amanda McWatters; Chun Li; Gordon B Mills; Robert C Bast
Journal:  Oncogene       Date:  2003-01-30       Impact factor: 9.867

9.  Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation.

Authors:  Jing Yang; Peter Cron; Vivienne Thompson; Valerie M Good; Daniel Hess; Brian A Hemmings; David Barford
Journal:  Mol Cell       Date:  2002-06       Impact factor: 17.970

Review 10.  Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis.

Authors:  Brendan D Manning
Journal:  J Cell Biol       Date:  2004-11-08       Impact factor: 10.539

View more
  22 in total

1.  Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.

Authors:  Jean Christopher Chamcheu; Vaqar M Adhami; Stephane Esnault; Mario Sechi; Imtiaz A Siddiqui; Kenneth A Satyshur; Deeba N Syed; Shah-Jahan M Dodwad; Maria-Ines Chaves-Rodriquez; B Jack Longley; Gary S Wood; Hasan Mukhtar
Journal:  Antioxid Redox Signal       Date:  2016-10-04       Impact factor: 8.401

Review 2.  The nuts and bolts of AGC protein kinases.

Authors:  Laura R Pearce; David Komander; Dario R Alessi
Journal:  Nat Rev Mol Cell Biol       Date:  2010-01       Impact factor: 94.444

3.  Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling.

Authors:  Deeba N Syed; Jean-Christopher Chamcheu; Mohammad Imran Khan; Mario Sechi; Rahul K Lall; Vaqar M Adhami; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2014-03-24       Impact factor: 5.858

4.  A conserved Glu-Arg salt bridge connects coevolved motifs that define the eukaryotic protein kinase fold.

Authors:  Jie Yang; Jian Wu; Jon M Steichen; Alexandr P Kornev; Michael S Deal; Sheng Li; Banumathi Sankaran; Virgil L Woods; Susan S Taylor
Journal:  J Mol Biol       Date:  2011-11-25       Impact factor: 5.469

5.  NMR solution structure of human vaccinia-related kinase 1 (VRK1) reveals the C-terminal tail essential for its structural stability and autocatalytic activity.

Authors:  Joon Shin; Goutam Chakraborty; Nagakumar Bharatham; Congbao Kang; Naoya Tochio; Seizo Koshiba; Takanori Kigawa; Wanil Kim; Kyong-Tai Kim; Ho Sup Yoon
Journal:  J Biol Chem       Date:  2011-05-03       Impact factor: 5.157

6.  Expression, purification and crystallization of human prolylcarboxypeptidase.

Authors:  Pravien D Abeywickrema; Sangita B Patel; Noel J Byrne; Ronald E Diehl; Dawn L Hall; Rachael E Ford; Keith W Rickert; John C Reid; Jennifer M Shipman; Wayne M Geissler; Kelly D Pryor; Ranabir SinhaRoy; Stephen M Soisson; Kevin J Lumb; Sujata Sharma
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-05-27

7.  A viral kinase mimics S6 kinase to enhance cell proliferation.

Authors:  Aadra Prashant Bhatt; Jason P Wong; Marc S Weinberg; Kurtis M Host; Louise C Giffin; Joshua Buijnink; Evert van Dijk; Yoshihiro Izumiya; Hsing-Jien Kung; Brenda R S Temple; Blossom Damania
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-24       Impact factor: 11.205

8.  Hydrophobic motif phosphorylation is not required for activation loop phosphorylation of p70 ribosomal protein S6 kinase 1 (S6K1).

Authors:  Malik M Keshwani; Sventja von Daake; Alexandra C Newton; Thomas K Harris; Susan S Taylor
Journal:  J Biol Chem       Date:  2011-05-11       Impact factor: 5.157

9.  MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1.

Authors:  Zhu-mei Shi; Jing Wang; Zhiping Yan; Yong-ping You; Chong-yong Li; Xu Qian; Yu Yin; Peng Zhao; Ying-ying Wang; Xie-feng Wang; Ming-na Li; Ling-Zhi Liu; Ning Liu; Bing-Hua Jiang
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Structural basis for the regulation of protein kinase A by activation loop phosphorylation.

Authors:  Jon M Steichen; Michael Kuchinskas; Malik M Keshwani; Jie Yang; Joseph A Adams; Susan S Taylor
Journal:  J Biol Chem       Date:  2012-02-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.